Related Experiment Video

Updated: May 8, 2026

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
07:39

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs

Published on: June 28, 2019

Senescence bypass in mesenchymal stem cells: a potential pathogenesis and implications of pro-senescence therapy in

Kanya Honoki1, Toshifumi Tsujiuchi

  • 1Department of Orthopedic Surgery, Nara Medical University, 840 Shijo-cho, Kashihara 634-8521, Japan. kahonoki@naramed-u.ac.jp

Expert Review of Anticancer Therapy
|August 30, 2013
PubMed

Insights

Cellular senescence limits cell lifespan and prevents cancer. Senescence bypass in mesenchymal stem cells may cause sarcoma, suggesting senescence induction therapy as a potential treatment.

Area of Science:

  • Cellular biology
  • Cancer research
  • Stem cell biology

Background:

  • Cellular senescence is a protective mechanism against cancer by limiting somatic cell lifespan.
  • Mesenchymal stem cells (MSCs) are crucial for tissue repair but can be sarcoma origins.
  • Understanding senescence in MSCs is key to exploring sarcoma pathogenesis.

Purpose of the Study:

  • To review senescence mechanisms in MSCs.
  • To hypothesize senescence bypass as a driver of sarcoma development.
  • To propose senescence induction therapy for sarcoma treatment.

Main Methods:

  • Literature review on cellular senescence and MSCs.
  • Analysis of senescence bypass as a potential sarcoma pathogenesis.
  • Exploration of senescence induction therapy for sarcomas.

Main Results:

  • Cellular senescence acts as a tumor suppressor mechanism.
  • Senescence bypass in MSCs is a potential pathway for sarcoma formation.
  • Senescence induction therapy may overcome chemo-resistance in sarcomas.

Conclusions:

  • Senescence bypass in MSCs is implicated in sarcoma development.
  • Senescence induction therapy offers a novel treatment strategy for sarcomas, including chemo-resistant types.
  • Targeting senescence in MSCs could be a promising therapeutic approach for sarcoma treatment.

More Related Videos

Evaluation of Injury-induced Senescence and In Vivo Reprogramming in the Skeletal Muscle09:14

Evaluation of Injury-induced Senescence and In Vivo Reprogramming in the Skeletal Muscle

Published on: October 26, 2017

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells08:56

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells

Published on: July 12, 2022

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...